Clinical efficacy and effectiveness of alternative varicella vaccination strategies: An overview of reviews. (15th November 2022)

• Record Type: Journal Article
• Authors: Ahern, Susan; Walsh, Kieran A.; Paone, Simona; Browne, John; Carrigan, Marie; Harrington, Patricia; Murphy, Aileen; Teljeur, Conor; Ryan, Máirín
• Is Part Of: Reviews in medical virology. Volume 33:Number 1(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-11-15
• Subjects: chickenpox -- immunisation -- overview of reviews -- vaccine effectiveness -- vaccine efficacy -- varicella; Medical virology -- Periodicals; Review Literature -- Periodicals; Virus Diseases -- Periodicals; Viruses -- Periodicals; 616.0194
• DOI: 10.1002/rmv.2407
• Languages: English
• ISSNs: 1052-9276

Abstract

Abstract: A number of countries have implemented universal childhood varicella vaccination programmes over the past 30 years. However, strategies differ in terms of dosing schedule (one‐ or two‐dose), type of vaccine(s) recommended (monovalent, quadrivalent measles‐mumps‐rubella‐varicella, or both), age at vaccination, and dosing interval for a two‐dose schedule. An overview of reviews was undertaken to assess the existing systematic review evidence of the clinical efficacy/effectiveness of alternative varicella vaccination strategies. A comprehensive search of databases, registries and grey literature was conducted up to 2 February 2022. Two reviewers independently screened, extracted data and assessed the methodological quality of included reviews. A total of 20 reviews were included in the overview; 17 assessed the efficacy/effectiveness of one‐dose strategies and 10 assessed the efficacy/effectiveness of two‐dose strategies. Although the quality of most reviews was deemed 'critically low', there was clear and consistent evidence that vaccination is very effective at reducing varicella. While the analysis was restricted due to lack of detail in reporting of the reviews, the evidence suggests that two‐dose strategies are more efficacious/effective than one‐dose strategies in preventing varicella of any severity, but that both strategies have similar high efficacy/effectiveness in preventing moderate or severe varicella. Based on this evidence in this overview of reviews, a key consideration for policymakers on the possible introduction of a childhood varicella vaccination programme and the choice between a one‐ or two‐dose strategy, will be whether the objective of a programme is to prevent varicella of any severity or to prevent moderate to severe varicella.